Skip to Content

392 G (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)

Pill with imprint 392 G is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 392 G

Carbidopa and levodopa extended release 25 mg / 100 mg 392 G
Carbidopa and levodopa extended release 25 mg / 100 mg 392 G
Carbidopa and levodopa extended release 25 mg / 100 mg 392 G

Carbidopa and Levodopa Extended Release

Imprint:
392 G
Strength:
25 mg / 100 mg
Color:
Purple
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals
Inactive Ingredients:
hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide